UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Apple
AAPL
|
+$615M |
| 3 |
NVIDIA
NVDA
|
+$609M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$1.07B |
| 2 |
Tesla
TSLA
|
+$467M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$262M |
| 4 |
Match Group
MTCH
|
+$241M |
| 5 |
Valero Energy
VLO
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.89% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 6.45% |
| 4 | Consumer Discretionary | 5.39% |
| 5 | Communication Services | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
CALL
T. Rowe Price
TROW
$24.3B
| $6.02M | ﹤0.01% |
55,300
+5,300
| +11% | +$582K |
|
|
2877
PUT
T. Rowe Price
TROW
$24.3B
| $6.02M | ﹤0.01% |
55,300
+5,300
| +11% | +$582K |
|
|
FOLD
2878
DELISTED
Amicus Therapeutics
FOLD
| $6.02M | ﹤0.01% |
563,972
+77,205
| +16% | +$841K |
|
|
PR
2879
Permian Resources
PR
$16.9B
| $6.02M | ﹤0.01% |
442,472
-119,887
| -21% | -$1.76M |
|
2880
OneSpaWorld
OSW
$2.66B
| $6.02M | ﹤0.01% |
364,528
-6,077
| -2% | -$96.2K |
|
2881
Noble Corp
NE
$6.51B
| $6.01M | ﹤0.01% |
166,305
+18,072
| +12% | +$728K |
|
2882
Saic
SAIC
$5.35B
| $6M | ﹤0.01% |
43,101
-47,296
| -52% | -$5.97M |
|
2883
iShares MSCI Peru and Global Exposure ETF
EPU
$567M
| $5.99M | ﹤0.01% |
138,796
-8,165
| -6% | -$332K |
|
2884
State Street SPDR S&P Software & Services ETF
XSW
$484M
| $5.99M | ﹤0.01% |
37,269
+606
| +2% | +$93.1K |
|
2885
International Seaways
INSW
$4.57B
| $5.99M | ﹤0.01% |
116,129
+36,293
| +45% | +$1.91M |
|
2886
PUT
Repligen
RGEN
$9.25B
| $5.98M | ﹤0.01% |
+40,200
| New | +$5.76M |
|
2887
JPMorgan BetaBuilders Japan ETF
BBJP
$18.8B
| $5.98M | ﹤0.01% |
100,811
-1,177
| -1% | -$67.8K |
|
2888
Gildan
GIL
$10.6B
| $5.97M | ﹤0.01% |
126,827
-27,114
| -18% | -$1.15M |
|
2889
Wendy's
WEN
$1.46B
| $5.97M | ﹤0.01% |
340,842
+15,137
| +5% | +$258K |
|
2890
Liberty Live Group Series C
LLYVK
$9.46B
| $5.97M | ﹤0.01% |
116,267
-456,355
| -80% | -$18.2M |
|
2891
Ocular Therapeutix
OCUL
$2.02B
| $5.96M | ﹤0.01% |
684,776
-63,957
| -9% | -$527K |
|
2892
Innoviva
INVA
$1.48B
| $5.95M | ﹤0.01% |
308,346
+29,442
| +11% | +$543K |
|
2893
Xerox
XRX
$425M
| $5.95M | ﹤0.01% |
573,560
+68,582
| +14% | +$734K |
|
2894
Credicorp
BAP
$30.7B
| $5.95M | ﹤0.01% |
32,870
-28,458
| -46% | -$4.85M |
|
2895
CALL
Edwards Lifesciences
EW
$51.7B
| $5.94M | ﹤0.01% |
90,000
+15,000
| +20% | +$1.09M |
|
|
CCRN
2896
DELISTED
Cross Country Healthcare
CCRN
| $5.94M | ﹤0.01% |
441,801
+76,889
| +21% | +$1.13M |
|
|
ETW
2897
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.06B
| $5.94M | ﹤0.01% |
684,035
+86,719
| +15% | +$720K |
|
2898
Hercules Capital
HTGC
$3.23B
| $5.94M | ﹤0.01% |
302,202
+51,208
| +20% | +$1.01M |
|
2899
Gentex
GNTX
$5.07B
| $5.93M | ﹤0.01% |
199,665
+38,000
| +24% | +$1.18M |
|
2900
Pacer Trendpilot US Mid Cap ETF
PTMC
$405M
| $5.92M | ﹤0.01% |
159,578
-336
| -0.2% | -$12K |
|
Similar funds
UBS Group's Q3 2024 Portfolio in Review
As of Q3 2024, UBS Group held 10,551 positions worth $459B, up 13% from $405B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS Group deployed $30.4B of net new capital in Q3 2024, opening 1,098 new positions and adding to 4,837 existing holdings. Its largest new stake was Smurfit Westrock: 973,061 shares worth $48.1M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Nike, an estimated $1.07B trimmed.
- UBS Group's largest Q3 2024 buy was Smurfit Westrock: 973,061 shares worth $48.1M.
- UBS Group added most to Meta Platforms (Facebook) in Q3 2024, an estimated $694M increase.
- UBS Group's biggest Q3 2024 reduction was Nike, cutting an estimated $1.07B.
- UBS Group fully exited WestRock Company in Q3 2024, selling an estimated $161M.
- UBS Group's ten largest holdings make up 17% of its $459B portfolio in Q3 2024.
- UBS Group opened 1,098 new positions and closed 1,108 in Q3 2024.
- UBS Group's portfolio value rose 13% quarter-over-quarter to $459B.
Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.